Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsINTRAVENOUSStandard

POHERDY

PERTUZUMAB-DPZB

Standard Dose
420MG/14ML(30MG/ML)
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Prescription
Summary

Approval overview POHERDY is listed in Drugs@FDA under application 761450 (BLA).

Review priority: STANDARD Marketing status: Prescription Active ingredient PERTUZUMAB-DPZB Form and strength INJECTABLE;INTRAVENOUS - 420MG/14ML(30MG/ML) Sponsor SHANGHAI HENLIUS BIOTECH Submission history Latest submission status date: 2025-11-13 00:00:00.

Structured Monograph

Clinical summary

Approval overview POHERDY is listed in Drugs@FDA under application 761450 (BLA). Review priority: STANDARD Marketing status: Prescription Active ingredient PERTUZUMAB-DPZB Form and strength INJECTABLE;INTRAVENOUS - 420MG/14ML(30MG/ML) Sponsor SHANGHAI HENLIUS BIOTECH Submission history Latest submission status date: 2025-11-13 00:00:00. Submission type: ORIG.

Monitoring

  • • Marketing status: Prescription
  • • Review priority: STANDARD

Interaction Notes

  • No interaction notes stored yet.